AI Generated Image
Rare transplant gives Stage 4 lung cancer patients a second chance at life - a Capitol Hill man is proof
WTOP • • health
Key Points:
- David Peterson, diagnosed with lung cancer in 2019, underwent a double lung transplant in 2023 at Northwestern Medicine after conventional treatments failed and his cancer became aggressive.
- Northwestern's DREAM program, launched in 2021, performs double lung transplants on select lung cancer patients, showing promising results with a 100% one-year survival rate among transplant recipients compared to 40% in non-recipients.
- The lung transplant approach was developed from techniques used during the COVID-19 pandemic to remove severely damaged lungs, and the study published in JAMA demonstrates comparable outcomes for cancer patients and other transplant recipients.
- Lung transplants are complex and rare, with challenges including high rejection risk and the need for patients to remain near the transplant center for monitoring, but the procedure offers new hope for patients with lung-limited malignancies.
- Peterson reports significant improvement in quality of life post-transplant, encouraging others in similar situations to seek treatment promptly at Northwestern Medicine.
